ZTS — All updates

3 entries loaded; 0 direction changes

Filter loaded records
“Zoetis ZTS - 15% Yearly Returns For The Next 15 Years?”Cited source: Michael Perry
$ZTSBullish
AI summary · ZTS looks an interesting value investment: at a P/E of 12, high ROIC, profitable margins despite a slight revenue outlook cut, and about $2B annual cash flow against $42B market value funding buybacks/dividends. The veterinary pharma oligopoly is expected to grow 10.73%; conservative 7% growth plus buybacks/dividends gives roughly 12% total return, accepted with pharma volatility and company uncertainty on US market stabilization. Michael Perry's 15%-for-15-years view is cited, but the speaker does not adopt it, concluding ZTS is very interesting and separate from the AI bubble.

I received many questions about Zoetis, a veterinary pharmaceutical company. Of course, when there are many comments, it means that the stock is low, and this stock is significantly low.

Moreover, Michael Perry sees it as a golden investment opportunity, implying potential returns of 15% annually for the next fifteen years. This means that your investment doubles after five years, then after ten years, and then doubles again. That is equivalent to 8 times the capital.

“Zoetis (ZTS) - The Stock Market Is Wrong About This”
$ZTSBullish
AI summary · ZTS is undervalued relative to historical multiples; strong FCF and balance sheet support a bull thesis on long-term growth potential.

has anyone ever heard out there of of the stocketis before? I did a video a long time ago about this company. I liked it then and stocks been absolutely crushed recently.

So, look at this um stock market drop. I'll just go last last year, if you will. So, $160 down to 180, excuse me, down to 80. If you zoom out, it's done nothing but go down for the last two years.

Um, despite revenue and earnings increasing. So, I think I think this is classic market multiple compression.

“Zoetis $ZTS - 5x Cash on Cash Gain? Stock Review”
$ZTSBullish
AI summary · ZTS fundamentals remain strong (growing revenue/EBITDA, high ROIC) while the stock price has collapsed to historical low multiples; this disconnect creates a bull case for ownership.

Thought we'd do a nice late night edition go through a cash flow one pager on this stock Zoetis. Uh it's a veterary stock. They make drugs for the vets use and uh the stock has been absolutely hammered recently.

Uh Michael Bur's taken a position. I thought I'd go through it.

if anyone ever heard out there of the stock Zoetas before, I did a video a long time ago about this company. I liked it then and stocks been absolutely crushed recently.

That's the earliest record
All updates for other tickers
Follow $ZTS30-day free trial
Start trial